Advertisement

Topics

FORMA Therapeutics, Inc. Company Profile

20:33 EST 15th December 2018 | BioPortfolio


News Articles [729 Associated News Articles listed on BioPortfolio]

FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investme...

Forma Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Forma Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Forma Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investme...

FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's FORMA Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investme...

Mars cambia su forma de hacer negocios a un año del lanzamiento del Plan Sostenible en Una ...

MCLEAN, Virginia, 18 de septiembre de 2018 /PRNewswire/ -- Mars está cambiando la forma en que hace negocios, a un año del lanzamiento de su Read more...

Cyan (158355634CYR) - The transformation continues

Edison Investment Research - Technology - Cyan: The acquisition of I-New transforms Cyan’s scale and growth prospects still further. Recent interim results highlighted a business on track to exc...

Honor 10 lanza de forma oficial su modelo de bandera más innovador de 2018 en Indonesia

- Honor 10 se lanza de forma oficial en Indonesia: el modelo de bandera más innovador de 2018 con fotografía con IA y un exquisito Read more...

How to solve a key bottle neck in the drug discovery process

In December 2014 Domainex and ZoBio joined forces to deliver crucial drug target information to support FORMA Therapeutics’ Drug Discovery Programs. PharmaVentures' Adrian Dawkes caught up with Ed...

CVS: Analyzing The Pro Forma Financial Statements

PubMed Articles [478 Associated PubMed Articles listed on BioPortfolio]

El mieloma múltiple (MM) puede afectar al tórax en forma de lesiones óseas, plasmocitomas, infiltraciones pulmonares y derrame pleural. El derrame pleural por infiltración de células plasmáticas...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

RNA-targeted therapeutics for lipid disorders.

To summarize recent developments in the field of RNA-directed therapeutics targeting lipid disorders that are not effectively managed.

A Review of Therapeutics in Clinical Development for Respiratory Syncytial Virus and Influenza in Children.

Respiratory syncytial virus (RSV) and influenza are important viral pathogens worldwide. Children, in particular, bear considerable burdens of morbidity and mortality associated with these viruses. Th...

El carcinoma de células escamosas de conjuntiva es una neoplasia de la superficie ocular que puede presentarse con distintos patrones macroscópicos. Presentamos el caso de un hombre de 75 años de e...

Clinical Trials [167 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

RF Rejuvenation for Pelvic Floor and Vagina

Evaluation of efficacy and safety of the Votiva RF system with the Forma V handpiece for vaginal treatments.

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1292 Associated Companies listed on BioPortfolio]

FORMA Therapeutics

FORMA Therapeutics unlocks intractable targets to create transformative small molecule therapies. The Company is achieving this by applying its proprietary cell-based screening, s...

FORMA Therapeutics, Inc.

FORMA Therapeutics Holdings, LLC

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "FORMA Therapeutics, Inc." on BioPortfolio

We have published hundreds of FORMA Therapeutics, Inc. news stories on BioPortfolio along with dozens of FORMA Therapeutics, Inc. Clinical Trials and PubMed Articles about FORMA Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of FORMA Therapeutics, Inc. Companies in our database. You can also find out about relevant FORMA Therapeutics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record